Journal of Controlled Release 2023

8 papers
The 2023 edition of the Journal of Controlled Release featured research focused on targeted drug delivery systems for oncology, neurology, and wound healing. A primary theme involved the development of nanocarriers for tumor immunotherapy, including the use of liposomes for targeted co-delivery and guanidine-modified nanoparticles to activate immune responses. Other oncology-related studies explored prodrug nanoassemblies and redox-responsive delivery systems designed to improve the efficacy and safety of treatments for conditions such as primary central nervous system lymphoma. Research also addressed localized delivery challenges through biomimetic hybrid nanovesicles for diabetic wounds and hyaluronic acid-modified cationic liposomes for skin penetration. In neurology, studies investigated ROS-responsive micelle systems to support mesenchymal stem cell therapy for ischemic stroke. The year’s publications further included insights into polymeric biomaterials for ophthalmic delivery. Notable contributors to these studies included Rui Wang, Dianlong Jia, Fengjiao Yuan, and Guangyong Li. This body of work reflects an emphasis on stimuli-responsive materials and biomimetic strategies to enhance therapeutic outcomes across diverse clinical applications.

Top Authors

AuthorPapers
Junbin Liu1
Pan Li1

Papers

Title
An insight on ophthalmic drug delivery systems: Focus on polymeric biomaterials-based carriers
Biomimetic hybrid nanovesicles improve infected diabetic wound via enhanced targeted delivery
Cabazitaxel prodrug nanoassemblies with branched chain modifications: Narrowing the gap between efficacy and safety
Cerebral delivery of redox-responsive lenalidomide prodrug plus methotrexate for primary central nerve system lymphoma combination therapy
Guanidine-modified nanoparticles as robust BTZ delivery carriers and activators of immune responses
Hyaluronic acid and HA-modified cationic liposomes for promoting skin penetration and retention
Surface-tethered ROS-responsive micelle backpacks for boosting mesenchymal stem cell vitality and modulating inflammation in ischemic stroke treatment
Targeted co-delivery of resiquimod and a SIRPα variant by liposomes to activate macrophage immune responses for tumor immunotherapy